|
|
 |
|
Viewing report
|
|
|
|
Prescription Drug Patches to 2015: Products, Indications, Markets and Opportunities
Greystone Associates, Aug 2011
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Patches relying on passive transport mechanisms have been limited in their ability to deliver new classes of drugs, but formulations employing penetration enhancers, and patch designs incorporating microporation and energy-assisted delivery are expanding the range of drugs that can be effectively delivered transdermally. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2015.
Highlights
- Analyzes and evaluates prescription skin patch products and assesses risks and market potential
- Analyzes patch designs, technologies and patch development issues
- Provides assessments of prescription skin patch products in two dozen key market segments
- Provides market data and forecasts to 2015
- Profiles patch manufacturers, their product development activities and strategies
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
